Subscribe To
Are real yields signaling a gold breakout?
US 10-Year real yields, which are the nominal yield of the US 10-Year minus inflation, traditionally have a strong inverse correlation with the price ...
October 11, 2023, 10:24 am
Eli lilly gets $14bn boost from ozempic data - here's what's happened
Eli Lilly and Co (NYSE:LLY) shares were trading 2.6% higher pre-market after a positive read-across from a key trial read-out from its main rival in t...
October 11, 2023, 8:53 am
Usd/jpy price outlook: yen fails to capitalise on safe-haven appeal
The war in the Middle East prompted a wider flight towards traditional safe-haven assets like gold and US Treasuries but there has been little impact ...
October 11, 2023, 8:31 am
Bitcoin fails to take flight on nasdaq tailwinds
Bitcoin (BTC) is facing another day of sharp downside following a bearish trading session on Tuesday. The benchmark cryptocurrency was skirting the $2...
October 11, 2023, 8:01 am
Nzdusd rally stops at key area
NZDUSD trades sideways amidst geopolitical developments The current short-term upleg started when NZDUSD fail<...
October 11, 2023, 7:50 am
Novo nordisk halts ozempic kidney trial. why it's bad for davita.
Novo Nordisk's Ozempic already is poised to disrupt a range of industries via its weight-loss benefits. Now it threatens companies which treat kidney ...
October 11, 2023, 7:24 am
Jpmorgan chase, big banks kick off q3 earnings season friday: 3 key questions for investors
JPMorgan Chase reports Q3 results and is expected to continue performing well. The earnings conference call will be closely watched for clues as to wh...
October 11, 2023, 7:02 am
Bitcoin price analysis: btc at risk if this support fails to hold
Bitcoin price is declining below $28,500 against the US Dollar. BTC might eye another increase if the bulls remain active above the $26,500 zone. Read...
October 11, 2023, 4:29 am
Dialysis company shares plunge after ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dial...
October 11, 2023, 3:59 am
Bitcoin faces death cross as xrp fails to capitalize on appeal ruling
Bitcoin and Ripple both under selling pressure despite the positive news on multiple fronts for Ripple. Is XRPUSD destined to return to its YTD low?.....
October 10, 2023, 7:39 pm
Alnylam: fda rejection of onpattro for attr-cm is a setback, but a manageable one
Despite a positive panel recommendation, the FDA rejected the Alnylam Pharmaceuticals, Inc. application to market Onpattro for ATTR-CM, citing a lack ...
October 10, 2023, 6:08 pm
Uniper: looking if there's any upside to this nationalized legacy player
I believe Fortum's divestment of its stake in Uniper was a major strategy failure in the utility sector...
October 10, 2023, 2:41 pm
Volvo's (vlvly) subsidiary mack trucks workers join uaw strike
Mack Trucks, Volvo's (VLVLY) subsidiary, faces a UAW strike after failing to reach an agreement with th...
October 10, 2023, 1:33 pm
Why shares of lexicon pharmaceuticals are up tuesday
Lexicon just launched heart failure therapy Inpefa this year. The drug was approved by the FDA in May....
October 10, 2023, 11:25 am
G.m. workers in canada go on strike
More than 4,000 members of the Unifor union went on strike at General Motors after the two sides failed...
October 10, 2023, 11:23 am
Audusd technical analysis - chances of more upside after the failed breakout
US:The Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher as the economy showed much ...
October 10, 2023, 11:08 am
Imax's china privatization proposal fails to reach shareholder threshold
Imax Corp.'s IMAX, -1.87% proposal to acquire Imax China's outstanding 96.3 million shares will not proceed following a vote by the company's China sh...
October 10, 2023, 8:46 am
Eur/usd: on a poor agenda, geopolitical tensions remains the main driver for the pair
EUR/USD is holding lower ground near 1.0550 in the European session, having failed to sustain the recov...
October 10, 2023, 8:29 am
Cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the...
October 10, 2023, 8:15 am
Lexicon pharmaceuticals shares rise on express scripts support for inpefa heart drug
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares jumped 9% in Tuesday pre-market trading after it announced that its Inpefa heart ...
October 10, 2023, 7:47 am